Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status

Patients with poor performance status treated with platinum based chemotherapy have a similar rate of toxicity compared to good performance status patients. Their overall survival was lower despite a similar response to chemotherapy.